197 related articles for article (PubMed ID: 20406449)
1. A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease.
Ayati BP; Edwards CM; Webb GF; Wikswo JP
Biol Direct; 2010 Apr; 5():28. PubMed ID: 20406449
[TBL] [Abstract][Full Text] [Related]
2. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
3. Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells.
Andersen TL; Søe K; Sondergaard TE; Plesner T; Delaisse JM
Br J Haematol; 2010 Feb; 148(4):551-61. PubMed ID: 19919653
[TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of the bone disease of multiple myeloma.
Edwards CM; Zhuang J; Mundy GR
Bone; 2008 Jun; 42(6):1007-13. PubMed ID: 18406675
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of bone homeostasis by bone cells].
Nakashima T
Clin Calcium; 2013 Feb; 23(2):218-28. PubMed ID: 23354089
[TBL] [Abstract][Full Text] [Related]
6. [Regulation of bone resorption by osteocytes].
Nakashima T; Hayash M; Takayanagi H
Clin Calcium; 2012 May; 22(5):685-96. PubMed ID: 22549193
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular mechanisms of bone remodeling.
Raggatt LJ; Partridge NC
J Biol Chem; 2010 Aug; 285(33):25103-8. PubMed ID: 20501658
[TBL] [Abstract][Full Text] [Related]
8. Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling.
Komarova SV; Smith RJ; Dixon SJ; Sims SM; Wahl LM
Bone; 2003 Aug; 33(2):206-15. PubMed ID: 14499354
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of myeloma-induced bone disease].
Abe M
Clin Calcium; 2016 May; 26(5):699-706. PubMed ID: 27117615
[TBL] [Abstract][Full Text] [Related]
10. Phenomenological model of bone remodeling cycle containing osteocyte regulation loop.
Moroz A; Crane MC; Smith G; Wimpenny DI
Biosystems; 2006 Jun; 84(3):183-90. PubMed ID: 16387419
[TBL] [Abstract][Full Text] [Related]
11. Multiple Myeloma and Bone: The Fatal Interaction.
Marino S; Roodman GD
Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 29229668
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone temporal effects on bone formation and resorption.
Kroll MH
Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
[TBL] [Abstract][Full Text] [Related]
13. Combined TUNEL and TRAP methods suggest that apoptotic bone cells are inside vacuoles of alveolar bone osteoclasts in young rats.
Cerri PS; Boabaid F; Katchburian E
J Periodontal Res; 2003 Apr; 38(2):223-6. PubMed ID: 12608919
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.
Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T
Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121
[TBL] [Abstract][Full Text] [Related]
15. A mathematical model of cell equilibrium and joint cell formation in multiple myeloma.
Koenders MA; Saso R
J Theor Biol; 2016 Feb; 390():73-9. PubMed ID: 26643942
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast function in myeloma.
Roodman GD
Bone; 2011 Jan; 48(1):135-40. PubMed ID: 20601285
[TBL] [Abstract][Full Text] [Related]
17. Aging of the Bone.
Wei Y; Sun Y
Adv Exp Med Biol; 2018; 1086():189-197. PubMed ID: 30232760
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of bone disease in multiple myeloma: from bench to bedside.
Terpos E; Ntanasis-Stathopoulos I; Gavriatopoulou M; Dimopoulos MA
Blood Cancer J; 2018 Jan; 8(1):7. PubMed ID: 29330358
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
Boissy P; Andersen TL; Abdallah BM; Kassem M; Plesner T; Delaissé JM
Cancer Res; 2005 Nov; 65(21):9943-52. PubMed ID: 16267019
[TBL] [Abstract][Full Text] [Related]
20. A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling.
Truesdell SL; George EL; Van Vranken CC; Saunders MM
J Vis Exp; 2020 May; (159):. PubMed ID: 32510503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
